Oral peptides often break down in the gut, although some are formulated to survive digestion
Baseline and interval laboratory monitoring should include: fasting glucose and HbA1c (tirzepatide can cause hypoglycemia in non-diabetic subjects if caloric intake drops too low), lipase and amylase (pancreatitis risk with GLP-1 agonists), liver function tests (AST, ALT, bilirubin), and thyroid panel (TSH, free T3, free T4)
The content of this website is for informational purposes only
It is prohibited In-Competition only as a specified stimulant under Section 6.b
During this consultation, we check your vitals and review your health history to tailor the treatment to your specific needs
Our team put together this quick-reference table to highlight the key differences